154 related articles for article (PubMed ID: 10457420)
21. Treatment of invasive fungal sinusitis with liposomal amphotericin B: a report of four cases.
Sungkanuparph S; Sathapatayavongs B; Kunachak S; Luxameechanporn T; Cheewaruangroj W
J Med Assoc Thai; 2001 Apr; 84(4):593-601. PubMed ID: 11460976
[TBL] [Abstract][Full Text] [Related]
22. Focus on fungal infections.
MacDougall DS
J Int Assoc Physicians AIDS Care; 1997 Jul; 3(7):27-32. PubMed ID: 11364470
[TBL] [Abstract][Full Text] [Related]
23. Liposomal amphotericin B trial marred by conclusions.
Wolf J; Buttery J; Daley AJ; Hanieh S; Shann F; Starr M; Curtis N
Clin Infect Dis; 2007 Sep; 45(5):667-8; author reply 668-9. PubMed ID: 17683011
[No Abstract] [Full Text] [Related]
24. Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience.
Cesaro S; Strugo L; Alaggio R; Cecchetto G; Rigobello L; Pillon M; Cusinato R; Zanesco L
Support Care Cancer; 2003 Nov; 11(11):722-7. PubMed ID: 13680324
[TBL] [Abstract][Full Text] [Related]
25. Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial.
Rijnders BJ; Cornelissen JJ; Slobbe L; Becker MJ; Doorduijn JK; Hop WC; Ruijgrok EJ; Löwenberg B; Vulto A; Lugtenburg PJ; de Marie S
Clin Infect Dis; 2008 May; 46(9):1401-8. PubMed ID: 18419443
[TBL] [Abstract][Full Text] [Related]
26. Cerebral aspergillosis: long term efficacy and safety of liposomal amphotericin B in kidney transplant.
Carlini A; Angelini D; Burrows L; De Quirico G; Antonelli A
Nephrol Dial Transplant; 1998 Oct; 13(10):2659-61. PubMed ID: 9794583
[No Abstract] [Full Text] [Related]
27. Successful treatment of brain aspergillosis with voriconazole.
Tattevin P; Bruneel F; Lellouche F; de Broucker T; Chevret S; Wolff M; Régnier B
Clin Microbiol Infect; 2004 Oct; 10(10):928-31. PubMed ID: 15373890
[TBL] [Abstract][Full Text] [Related]
28. Randomized trial of lipid-based amphotericin B for invasive aspergillosis in neutropenic hosts is an important step forward.
Karp JE; Merz WG
Clin Infect Dis; 1998 Dec; 27(6):1413-4. PubMed ID: 9868652
[No Abstract] [Full Text] [Related]
29. Isolated cerebral aspergillosis without a portal of entry--complete recovery after liposomal amphotericin B and surgical treatment.
García A; Mazuecos A; Clayo A; Pérez-Requena J; Mangas A; Alonso F; Ceballos M; Rivero M
Nephrol Dial Transplant; 1998 Sep; 13(9):2385-7. PubMed ID: 9761532
[No Abstract] [Full Text] [Related]
30. [Cerebral aspergillosis].
Yamaguchi H
Ryoikibetsu Shokogun Shirizu; 1999; (24 Pt 2):304-7. PubMed ID: 10201208
[No Abstract] [Full Text] [Related]
31. Post-traumatic intracranial epidural Aspergillus fumigatus abscess.
Letscher V; Herbrecht R; Gaudias J; Taglang G; Koenig H; Dupuis MG; Waller J
J Med Vet Mycol; 1997; 35(4):279-82. PubMed ID: 9292425
[TBL] [Abstract][Full Text] [Related]
32. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.
Hachem RY; Boktour MR; Hanna HA; Husni RN; Torres HA; Afif C; Kontoyiannis DP; Raad II
Cancer; 2008 Mar; 112(6):1282-7. PubMed ID: 18224662
[TBL] [Abstract][Full Text] [Related]
33. Intracerebral aspergillosis following allogeneic marrow transplantation responding to treatment with non-liposomal amphotericin B and rifampicin.
Proctor SJ; Jackson GH
Br J Haematol; 1997 Sep; 98(4):1052-3. PubMed ID: 9326214
[No Abstract] [Full Text] [Related]
34. Aggressive cutaneous aspergillus infection: control by local irrigation with amphotericin B.
Abbas AA; Felimban SK; Yousef AA; Khattab TM; Fryer CJ; Nandagopal N
Med Pediatr Oncol; 2002 Aug; 39(2):139-40. PubMed ID: 12116066
[No Abstract] [Full Text] [Related]
35. Combination therapy with terbinafine and amphotericin B in a rabbit model of experimental invasive aspergillosis.
Kirkpatrick WR; Vallor AC; McAtee RK; Ryder NS; Fothergill AW; Rinaldi MG; Patterson TF
Antimicrob Agents Chemother; 2005 Nov; 49(11):4751-3. PubMed ID: 16251321
[TBL] [Abstract][Full Text] [Related]
36. FDA clears new treatment for invasive aspergillosis.
Oncol Nurs Forum; 1997; 24(1):107. PubMed ID: 9007912
[No Abstract] [Full Text] [Related]
37. Liposomal amphotericin B for fever and neutropenia.
Prentice HG; Kibbler CC
N Engl J Med; 1999 Oct; 341(15):1152-3; author reply 1154-5. PubMed ID: 10515751
[No Abstract] [Full Text] [Related]
38. A novel murine model of cerebral scedosporiosis: lack of efficacy of amphotericin B.
Capilla J; Mayayo E; Serena C; Pastor FJ; Guarro J
J Antimicrob Chemother; 2004 Dec; 54(6):1092-5. PubMed ID: 15509616
[TBL] [Abstract][Full Text] [Related]
39. Native valve Aspergillus endocarditis in two patients with aplastic anaemia.
Petrikkos GL; Skiada A; Samonis G; Mavroudis D; Daikos GL
Scand J Infect Dis; 2006; 38(10):916-20. PubMed ID: 17008238
[TBL] [Abstract][Full Text] [Related]
40. Nephrogenic diabetes insipidus induced by two amphotericin B liposomal formulations.
Metzger NL; Varney Gill KL
Pharmacotherapy; 2009 May; 29(5):613-20. PubMed ID: 19397468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
